Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 1,101–1,200 of 3,347
A new generation of AD biomarkers: 2019 to 2021
Hawksworth, J. I., Fernández, E., & Gevaert, K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101654 · Cited by 37
Visconte, C., Golia, M. T., Fenoglio, C., Serpente, M., Gabrielli, M., Arcaro, M., Sorrentino, F., Busnelli, M., Arighi, A., Fumagalli, G., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00746-0 · Cited by 36
Disease-associated astrocytes and microglia markers are upregulated in mice fed high fat diet
Lin, L., Basu, R., Chatterjee, D., Templin, A. T., Flak, J. N., & Johnson, T. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-39890-0 · Cited by 44
“While the complement cascade can have both inflammatory and neuroprotective functions, complement activity has been associated with the loss of synapses in mouse AD models 63 .”
BackgroundMiao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 42
“CD11b is highly expressed on microglia in the CNS and has been reported to regulate microglial phagocytosis and migration [137, 138]. α-Syn fibrils bind to CD11b to cause mtROS production through the RhoA/ROCK pathway to activate the NLRP3 inflammasome [139].”
BackgroundChagas, L. D. S., & Serfaty, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073819 · Cited by 53
“There are increasing studies in the literature assessing the implications of C1q as an early driver of synaptic loss in neurodegenerative and neuroinflammatory conditions [91,92] (reviewed in [93]).”
BackgroundWang, J., Gao, S., Fu, S., Li, Y., Su, L., Li, X., Wu, G., Jiang, J., Zhao, Z., Yang, C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.019 · Cited by 42
“In addition, microglia can directly impact neuronal functions through pruning of synapses (Hong, 2016; Wang, 2020).”
A role for microglia in mediating the microbiota–gut–brain axis
Keane, L., Clarke, G. A., & Cryan, J. F. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01188-9 · Cited by 48
Yarbro, J. M., Shrestha, H. K., Wang, Z., Zhang, X., Zaman, M., Chu, M., Wang, X., Yu, G., & Peng, J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00874-5 · Cited by 46
“Complement components mediate pathogenic synaptic elimination via complement receptor-dependent microglial pruning of synapses [148, 149].”
Central Nervous System: (Immunological) Ivory Tower or Not?
Marin, I. A., & Kipnis, J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.122 · Cited by 39
“Intriguingly, in mouse models of Alzheimer’s disease with its hallmark microglial activation and proliferation, the effects of microglial ablation are beneficial (Hong et al, 2016; Olmos-Alonso et al, 2016; Spangenberg et al, 2016).”
BackgroundLi, L.-H., Tian, X.-R., Peng, W.-N., Deng, Y., & Li, J.-J. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.265564 · Cited by 35
“…disorders (Dodich et al., 2016; Lin et al., 2018; Mokhtar et al., 2018; Zhang et al., 2019), and is pathologically characterized by the presence of extracellular amyloid plaques, intracellular neurofibrillary tangles, and synapse loss (Hong et al., 2016; Zhao, 2016; Filadi and Pizzo, 2019).”
BackgroundLee, H.-J., Woo, H., Lee, H.-E., Jeon, H., Ryu, K.-Y., Nam, J. H., Jeon, S. G., Park, H., Lee, J.-S., Han, K.-M., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.030 · Cited by 36
Hippocampal alpha-synuclein mediates depressive-like behaviors
Du, T., Li, G., Luo, H., Pan, Y., Xu, Q., & Ma, K. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.03.020 · Cited by 34
New insights in drug development for Alzheimer's disease based on microglia function
Qiao, O., Ji, H., Zhang, Y., Zhang, X., Zhang, X., Liu, N., Huang, L., Liu, C., & Gao, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111703 · Cited by 35
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
Abd‐Elrahman, K. S., Sarasija, S., & Ferguson, S. S. G. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210916102638 · Cited by 42
Ruiz‐Pérez, G., Esteban, S. R. D. M., Marqués, S., Aparicio, N., Grande, M. T., Benito‐Cuesta, I., Martínez-Relimpio, A. M., Arnanz, M. A., Tolón, R. M., Posada-Ayala, M., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02276-y · Cited by 42
Joseph, K., Kirsch, M., Johnston, M., Münkel, C., Stieglitz, T., Haas, C. A., & Hofmann, U. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121230 · Cited by 37
Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction
Bourseguin, J., Cheng, W., Talbot, E., Hardy, L., Lai, J. F., Jeffries, A. M., Lodato, M. A., Lee, E. A., & Khoronenkova, S. V. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac104 · Cited by 38
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
Kass, B., Schemmert, S., Zafiu, C., Pils, M., Bannach, O., Kutzsche, J., Bujnicki, T., & Willbold, D. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100630 · Cited by 39
Levin, L. A., Patrick, C., Choudry, N. B., Sharif, N. A., & Goldberg, J. L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.964197 · Cited by 40
“In other cases, specific categories of inflammation within the nervous system can either facilitate neuroprotection or mediate physiological or developmental neuronal mechanisms, such as complementmediated synaptic pruning relevant to AD (90, 91).”
BackgroundMovers and shakers: Microglial dynamics and modulation of neural networks
Whitelaw, B. S., Stoessel, M. B., & Majewska, A. K. (2022) · Glia · doi:10.1002/glia.24323 · Cited by 35
Aging Shapes the Population-Mean and -Dispersion of Gene Expression in Human Brains
Brinkmeyer-Langford, C. L., Guan, J., Ji, G., & Cai, J. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00183 · Cited by 35
Microglial phagocytosis in Alzheimer disease
Brown, G. C., St George-Hyslop, P., Paolicelli, R. C., & Lemke, G. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-025-01162-y · Cited by 36
“In mice, injection of oligomeric Aβ into the lateral ventricles upregulated complement and microglial engulfment of postsynaptic structures 50 .”
InfluentialRam, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Li, L., Yu, L., He, B., Li, H., Ji, H., Wang, Y., Hu, Y., Hu, Y., Zhou, Y., Yang, T., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02271-3 · Cited by 41
“to the progression of neuropathology [7, 8].”
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
Brody, A. H., Nies, S. H., Guan, F., Smith, L. M., Mukherjee, B., Salazar, S. A., Lee, S., Lam, T. K. T., & Strittmatter, S. M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00526-y · Cited by 38
“Expression of C1q is augmented in response to both injury and Aβ exposure, and increased levels of C1q deposition at synapses are associated with microglia-mediated synaptic engulfment and synapse loss in models of neurogenerative diseases such as AD and FTD [62, 63].”
Local translation in microglial processes is required for efficient phagocytosis
Vasek, M. J., Mueller, S. M., Fass, S. B., Deajon-Jackson, J. D., Liu, Y., Crosby, H. W., Koester, S. K., Yi, J., Li, Q., & Dougherty, J. D. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01353-0 · Cited by 38
Chen, L., Sun, Y., Li, J., Liu, S., Ding, H., Wang, G., & Li, X. (2023) · Cells · doi:10.3390/cells12232672 · Cited by 47
“Additionally, the activation of the complement system might amplify the phagocytic function of the microglia, risking inappropriate synaptic elimination [10].”
BackgroundMicroglia modulate the cerebrovascular reactivity through ectonucleotidase CD39
Fu, Z., Ganesana, M., Hwang, P. H., Tan, X., Kinkaid, M. M., Sun, Y., Bian, E. J., Weybright, A., Chen, H., Sol‐Church, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56093-5 · Cited by 44
“They both exert phagocytosis and maintain the brain homeostasis 16 – 19 .”
Dysregulated Metabolism of the Amyloid‐β Protein and Therapeutic Approaches in Alzheimer Disease
Kikuchi, K., Kidana, K., Tatebe, T., & Tomita, T. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26129 · Cited by 40
“Intriguingly, C3 was implicated not only in Ab clearance but also in synaptic loss in a mouse model of AD [Hong et al., 2016].”
BackgroundScaling Synapses in the Presence of HIV
Green, M. V., Raybuck, J. D., Zhang, X., Wu, M. M., & Thayer, S. A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2502-2 · Cited by 39
Lim, S., Rodríguez‐Ortiz, C. J., Hsu, H.-W., Wu, J., Zumkehr, J., Kilian, J., Vidal, J., Ayata, P., & Kitazawa, M. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126578 · Cited by 35
Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques
Natunen, T., Martiskainen, H., Marttinen, M., Gabbouj, S., Koivisto, H., Kemppainen, S., Kaipainen, S., Takalo, M., Svobodová, H., Leppänen, L., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00415-2 · Cited by 35
Astrocyte subtype-specific approach to Alzheimer's disease treatment
Sarkar, S., & Biswas, S. C. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104956 · Cited by 40
Establishment and Maintenance of Neural Circuit Architecture
Heckman, E. L., & Doe, C. Q. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1143-20.2020 · Cited by 38
“Indeed, the hallmark of many neurodegenerative diseases is a loss of synapses resulting in the destabilization of axons or dendrites (Terry et al., 1991; Scheff et al., 2006; Lin and Koleske, 2010; Hong et al., 2016; Mariano et al., 2018; Sauerbeck et al., 2020).”
BackgroundAlldred, M. J., Penikalapati, S. C., Lee, S. H., Heguy, A., Roussos, P., & Ginsberg, S. D. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02453-3 · Cited by 35
“Changes inDlg4 have been linked to early synapse loss in AD mouse models and human postmortem AD studies [122, 123].”
BackgroundAn overview of microglia ontogeny and maturation in the homeostatic and pathological brain
Mendes, M. S., & Majewska, A. K. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15225 · Cited by 39
“, 2011) or neurotrophic factors (Hong et al., 2016; Miyamoto et al., 2016; Paolicelli et al., 2011; Parkhurst et al., 2013; Schafer et al., 2012) (Figure 1).”
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction
Mancini, A., Ghiglieri, V., Parnetti, L., Calabresi, P., & Filippo, M. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644294 · Cited by 42
Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b
Jensen, R. K., Bajic, G., Şen, M., Springer, T. A., Vorup‐Jensen, T., & Andersen, G. R. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001208 · Cited by 43
Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones
Wu, Y., Hang, Z., Tong, L., & Du, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03784-w · Cited by 35
Structural insight into proteolytic activation and regulation of the complement system
Schatz-Jakobsen, J. A., Pedersen, D. V., & Andersen, G. R. (2016) · Immunological Reviews · doi:10.1111/imr.12465 · Cited by 38
Specialized functions of resident macrophages in brain and heart
Nicolás-Ávila, J. Á., Hidalgo, A., & Ballesteros, I. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0118-041r · Cited by 37
Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists
Gunther, E. C., Smith, L. M., Kostylev, M. A., Cox, T. O., Kaufman, A. C., Lee, S., Folta-Stogniew, E., Maynard, G. D., Um, J. W., Stagi, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.021 · Cited by 35
CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
Finneran, D. J., Morgan, D., Gordon, M. N., & Nash, K. R. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9822-5 · Cited by 34
“Produced as a transmembrane protein, FKN can undergo proteolytic cleavage by a disintegrin and metalloprotease (ADAM) 10/17 or cathepsin S to produce a secreted, soluble form of the protein (sFKN) (Garton et al. 2001; Hundhausen et al. 2003; Jones et al. 2013).”
BackgroundLiu, J., Zhu, Z., & Leung, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.818602 · Cited by 45
Regulation of microglia phagocytosis and potential involvement of exercise
Li, C., Wang, Y., Xing, Y., Han, J., Zhang, Y., Zhang, A., Hu, J., Hua, Y., & Bai, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.953534 · Cited by 40
Zheng, Y., Fan, L., Xia, S., Yang, Q., Zhang, Z., Chen, H., Zeng, H., Fu, X., Peng, Y., Xu, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919444 · Cited by 43
“Previous studies have indicated that C1q/C3-CR3 signaling is involved in phagocyte-mediated phagocytosis (11, 12, 21).”
BackgroundZahedi, E., Sadr, S. S., Sanaeierad, A., & Roghani, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114848 · Cited by 35
Zhang, C., Qi, H., Jia, D., Zhao, J., Xu, C., Liu, J., Cui, Y., Zhang, J., Wang, M., Chen, M., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122457 · Cited by 40
Current evidence of synaptic dysfunction after stroke: Cellular and molecular mechanisms
Li, C., Jiang, M., Fang, Z., Chen, Z., Li, L. L., Liu, Z., Wang, J., Yin, X., Wang, J., & Wu, M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14744 · Cited by 47
“45,73,74 79 Microglia achieve synapse elimination through the complement system, and the inhibition of complement system activation blocks synapse loss.”
BackgroundPharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives
Xie, P.-L., Zheng, M.-Y., Han, R., Chen, W., & Mao, J.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1366061 · Cited by 48
Nonapoptotic caspase-3 guides C1q-dependent synaptic phagocytosis by microglia
Andoh, M., Shinoda, N., Taira, Y., Araki, T., Kasahara, Y., Takeuchi, H., Miura, M., Ikegaya, Y., & Koyama, R. (2025) · Nature Communications · doi:10.1038/s41467-025-56342-7 · Cited by 36
“Furthermore, employing a febrile seizure model, the authors demonstrate that microglial engulfment of inhibitory synapses in the hippocampus in vivo occurs through a molecular mechanism dependent on caspase-3 activation.”
Yaribash, S., Mohammadi, K., & Sani, M. A. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01544-2 · Cited by 46
“Microgliosis can have roles in the phagocytosis of damaged synapses, like events in Alzheimer’s disease (Hong et al. 2016).”
Immune modulation to treat Alzheimer’s disease
Duggan, M. R., Morgan, D., Price, B. R., Rajbanshi, B., Martín‐Peña, A., Tansey, M. G., & Walker, K. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00828-x · Cited by 49
Hatch, R. J., Leinenga, G., & Götz, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164278 · Cited by 34
“In fact, a recent study has reported that microgliamediate synapse loss at an early time-point in ADmouse models [37].”
BackgroundHenson, M. A., Tucker, C. J., Zhao, M., & Dudek, S. M. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.10.013 · Cited by 42
Neuroimmune Biomarkers in Mental Illness
Herron, J. W., Nerurkar, L., & Cavanagh, J. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_45 · Cited by 37
Chunchai, T., Apaijai, N., Keawtep, P., Mantor, D., Arinno, A., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Acta Physiologica · doi:10.1111/apha.13229 · Cited by 35
“Growing evidence has demonstrated the crucial roles of microglia and astrocytes on cognitive dysfunction in neurodegenerative disorders.(8,9,51,52) Moreover, it has been shown that testosterone‐depleted male mice had decreased tight junction proteins such as claudin‐5 and ZO‐1 and increased blood‐brain barrier (BBB) p…”
BackgroundThe Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
Merlo, S., Spampinato, S. F., Caruso, G. I., & Sortino, M. A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200131105418 · Cited by 37
Sapp, E., Seeley, C., Iuliano, M., Weisman, E., Vodička, P., DiFiglia, M., & Kegel-Gleason, K. B. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104950 · Cited by 32
“The increase we observed in Complement component 1 Q subcomponent-binding protein could impact the pruning of synapses by microglia which has been observed in a mouse model of Alzheimer's disease (Hong et al., 2016).”
BackgroundGuo, X., Rao, Y., Mao, R., Cui, L., & Fang, Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108336 · Cited by 38
Salvany, S., Casanovas, A., Piedrafita, L., Tarabal, O., Hernández, S., Calderó, J., & Esquerda, J. E. (2021) · Glia · doi:10.1002/glia.23959 · Cited by 38
Lu, J., Hou, L., Zhang, D., Li, S., Ruan, Z., Zhang, X., Hong, J., & Wang, Q. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s299927 · Cited by 34
Self-citationThe complement cascade repurposed in the brain
Stevens, B., & Johnson, M. B. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00621-z · Cited by 37
Self-citationYednock, T. A., Fong, D. S., & Lad, E. M. (2022) · International Journal of Retina and Vitreous · doi:10.1186/s40942-022-00431-y · Cited by 38
“C1q inhibition has been shown to be protective in multiple animal models of neurodegeneration by blocking complement-mediated synapse elimination in the central nervous system (CNS), including models of Alzheimer’s disease [16, 19, 100], spinal muscular atrophy [101], glaucoma [14, 18], photoreceptor cell damage [11],…”
BackgroundIkzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration
Ballasch, I., García-García, E., Vila, C., Pérez-González, A., Sancho‐Balsells, A., Fernández, J., Soto, D., Puigdellívol, M., Gasull, X., Alberch, J., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.016 · Cited by 38
Cortes, M., Cao, M., Liu, H. L., Moore, C. S., Durosier, L. D., Burns, P., Fecteau, G., Desrochers, A., Barreiro, L. B., Antel, J. P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09439-z · Cited by 36
“Hyperactive microglia may prevent physiological 298 synaptogenesis predisposing to Alzheimer’s disease (AD) later in life.(29),(30) The mediating pathway 299 involves microglial-neuronal complement signaling suggesting that microglia could be potential early 300 therapeutic targets in AD prevention or treatment and in…”
BackgroundInfluentialMagro‐Checa, C., Kumar, S., Ramiro, S., de Voorde, L. J. J. B.-V., Eikenboom, J. C. J., Ronen, I., de Bresser, J., van Buchem, M. A., Huizinga, T. W. J., & Steup‐Beekman, G. M. (2018) · Lupus · doi:10.1177/0961203318816819 · Cited by 39
Matera, A., Compagnion, A.-C., Pedicone, C., Kotah, J. M., Ivanov, A., Monsorno, K., Labouèbe, G., Leggio, L., Pereira-Iglesias, M., Beule, D., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.11.003 · Cited by 34
“1,38,39,62,64,65 We discovered that SHIP1 in the hippocampus follows a similar trajectory, supporting the important function of this protein in development.”
He, S., Li, X., Mittra, N., Bhattacharjee, A., Wang, H., Song, S., Zhao, S., Liu, F., & Han, X. (2025) · Advanced Science · doi:10.1002/advs.202410910 · Cited by 34
Welcome, M. O., & Mastorakis, N. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105557 · Cited by 38
Wang, G., Yin, W., Shin, H., Tian, Q., Lü, W., & Hou, X. S. (2021) · Nature Aging · doi:10.1038/s43587-021-00130-7 · Cited by 42
Three Different Types of β-Glucans Enhance Cognition: The Role of the Gut-Brain Axis
Hu, M., Zhang, P., Wang, R. L., Zhou, M., Pang, N., Cui, X., Ge, X., Liu, X., Huang, X., & Yu, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.848930 · Cited by 63
“Besides, microglia are the major source of inflammatory cytokines in CNS to induce neuro inflammation, the main mechanism underlying various neurodegenerative diseases (55, 56).”
BackgroundSynaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 35
He, Y., Xu, D., Yan, Z., Wu, Y., Zhang, Y., Tian, X., Zhu, J., Liu, Z., Cheng, W., Zheng, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1043572 · Cited by 35
“Furthermore, microglia can also induce synaptic damage and neuronal degeneration via complement system-mediated synaptic engulfing (23, 83).”
BackgroundLi, Y., Yin, Q., Li, Q., Huo, A., Shen, T., Cao, J.-Q., Liu, C., Liu, T., Luo, W., & Cong, Q. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01058-x · Cited by 56
“The complement system activates microglia to aberrantly engulf synapses, resulting in the synapse loss observed in the hippocampus related to cognitive decline [19, 23, 65].”
BackgroundPhysical exercise regulates microglia in health and disease
Strohm, A. O., & Majewska, A. K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1420322 · Cited by 38
Biomarkers of synaptic degeneration in Alzheimer’s disease
Cheng, Q., Fan, Y., Zhang, P., Liu, H., Han, J., Yu, Q., Wang, X., Wu, S., & Lu, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102642 · Cited by 42
Esculentoside A exerts anti-inflammatory activity in microglial cells
Yang, H., Chen, Y., Yu, L., & Xu, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.014 · Cited by 35
Fumagalli, S., Fiordaliso, F., Perego, C., Corbelli, A., Mariani, A., Paola, M. D., & Simoni, M. G. D. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1401-z · Cited by 36
“SIM has been successfully applied to analyze engulfed synapses by microglia in the developing or diseased brain on histological preparation [45].”
MethodDoré, K., & Malinow, R. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.020 · Cited by 37
“PSD-95 levels are also reduced in several mouse models of Alzheimer’s disease (Hong et al., 2016; Shao et al., 2011) as well as in human patients with the disease (Gylys et al.”
BackgroundLuo, Y., Huang, L., Liao, P. S., & Jiang, R. (2021) · Neural Plasticity · doi:10.1155/2021/8643129 · Cited by 35
“Disruption of microglial function leads to several diseases, and microglia-mediated neuroinflammation, associated with synaptic loss and cognitive decline [115], is a characteristic of late AD.”
BackgroundBello-Medina, P. C., González-Franco, D. A., Vargas-Rodríguez, I., & Díaz-Cintra, S. Y. (2021) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.06.008 · Cited by 41
de Soysa, Y., Therrien, M., Walker, A. C., & Stevens, B. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101651 · Cited by 37
Self-citationNeuronal glutathione loss leads to neurodegeneration involving gasdermin activation
Hashimoto, S., Matsuba, Y., Takahashi, M., Kamano, N., Watamura, N., Sasaguri, H., Takado, Y., Yoshihara, Y., Saito, T., & Saido, T. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-27653-w · Cited by 40
Kata, D., Földesi, I., Fehér, L. Z., Hackler, L., Puskás, L. G., & Gulya, K. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.009 · Cited by 35
Lanser, A. J., Rezende, R. M., Rubino, S. J., Lorello, P. J., Donnelly, D. J., Xu, H., Lau, L. A., Dulla, C. G., Caldarone, B. J., Robson, S. C., et al. (2017) · Immunology · doi:10.1111/imm.12798 · Cited by 35
Anti‐PrPC antibody rescues cognition and synapses in transgenic alzheimer mice
Cox, T. O., Gunther, E. C., Brody, A. H., Chiasseu, M. T., Stoner, A., Smith, L. M., Haas, L. T., Hammersley, J., Rees, G., Dosanjh, B., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.730 · Cited by 33
“In brief, anti-PrP antibodies were isolated from an M13-based human singlechain variable fragments (scFv)-phage display library(32) using an alternating series of selections against biotinylated human and cynomolgus PrP(23-111).”
BackgroundMethodInfluentialLin, Z., Hou, G., Yao, Y., Zhou, Z., Zhu, F., Liu, L., Zeng, L., Yang, Y., & Ma, J. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.739333 · Cited by 35
TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology
Yu, C.-J., Wang, M., Ruiyang, L., Wei, T., Yang, H.-C., Yin, Y., Mi, Y., Qin, Q., & Tang, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03100-1 · Cited by 36
“C1q is required to inhibit LTP induced by Aβ oligomers [9].”
BackgroundPanes-Fernández, J., Godoy, P. A., Gavilán, J., Ramírez-Molina, O., Burgos, C. F., Marileo, A. M., Flores-Núñez, O., Castro, P. A., Moraga‐Cid, G., Yévenes, G. E., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114596 · Cited by 34
Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
Mrza, M. A., He, J., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063148 · Cited by 34
“Several molecules have been identified in microglia-neuron contacts at synapses, including Fractalkine (CX3CL1)/fractalkine receptor (CX3CR1) [29], CD200/CD200R [30], and the complement system [31].”
BackgroundHuang, S., Yang, Z., Cheng, J., Li, H.-Y., Chen, S., Huang, Z.-H., Chen, J.-D., Xiong, R.-G., Yang, M.-T., Wang, C., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103578 · Cited by 36
“These alterations aligned with previous research indicating that oxidative stress and neuroinflammation could lead to similar impairments in synaptic structure and function, ultimately contributing to cognitive deficits [62, 75,77].”
Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease
Horowitz, A. M., & Villeda, S. A. (2017) · F1000Research · doi:10.12688/f1000research.11437.1 · Cited by 32
Duggan, S. P., Garry, C., Behan, F. M., Phipps, S., Kudo, H., Kirca, M., Zaheer, A., McGarrigle, S. A., Reynolds, J. V., Goldin, R. D., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.01.012 · Cited by 34
Unravelling the glial response in the pathogenesis of Alzheimer's disease
Alibhai, J. D., Diack, A. B., & Manson, J. C. (2018) · The FASEB Journal · doi:10.1096/fj.201801360r · Cited by 31
CD200 dysfunction in neuron contributes to synaptic deficits and cognitive impairment
Feng, D., Huang, A., Yan, W., & Chen, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.134 · Cited by 36
Li, Y., Zhang, X., & Li, Y. (2019) · CNS Spectrums · doi:10.1017/s1092852919001603 · Cited by 35
Werner, C. T., Williams, C. J., Fermelia, M. R., Lin, D., & Li, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01174 · Cited by 34
West Nile Virus-Induced Neurologic Sequelae—Relationship to Neurodegenerative Cascades and Dementias
Vittor, A. Y., Long, M. T., Chakrabarty, P., Aycock, L., Kollu, V., & DeKosky, S. T. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00200-7 · Cited by 36
Laursen, N. S., Pedersen, D. V., Gytz, H., Zarantonello, A., Jensen, J. M. B., Hansen, A. G., Thiel, S., & Andersen, G. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01504 · Cited by 33
“However, the same pathway that ensures correct development by pruning excess synapses, seems to be involved in neurodegenerative conditions like AD (62).”
BackgroundInfluential
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.